L. Wang

Phase II trial of vorinostat in advanced melanoma

Naomi B. Haas, Ian Quirt, Sebastién J. Hotte et al. · Investigational New Drugs · 2014 · 70 citations

Medicine, Oncology, Pharmacotherapy +13

Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Michael Velec, Tim Craig, L. Wang et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 63 citations

Medicine, Oncology, Radiation Oncology +12

A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia

Helen Mackay, Ronald J. Buckanovich, Hal W. Hirte et al. · Gynecologic Oncology · 2011 · 54 citations

Medicine, Oncology, Surgery +13

A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the Princess Margaret Hospital, The University of Chicago, and California Cancer Phase II Consortia.

Rosângela da Silveira Corrêa, Helen Mackay, Hal W. Hirte et al. · Journal of Clinical Oncology · 2010 · 30 citations

Medicine, Oncology, Pharmacology +17

Phase II trial of erlotinib in advanced pancreatic cancer (PC)

Patricia A. Tang, Sharlene Gill, H. Au et al. · Journal of Clinical Oncology · 2009 · 15 citations

Medicine, Oncology, Pharmacology +17